Case Study | EU registration of a Biosimilar

July 19, 2022

Have a look at a recent success story of how Asphalion achieved Marketing authorization for a biosimilar medicine for a company located in East Asia that wanted to access the EU market.

Thanks to our extensive track record of over 20 year at Asphalion we can assist you with your all CMC activities, non-CMC specific ones and with all other kind of projects.

CLICK HERE TO SEE THE CASE STUDY IN DETAIL

For further information you can contact us at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

ETERNAL | 6th General Assembly meeting

The 6th General Assembly meeting of the ETERNAL project successfully wrapped up last week! Hosted by Universität für Bodenkultur Wien, the meeting featured valuable updates

EVENT | DIA Europe

DIA Europe 2025 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2025 will be the prime opportunity to discuss how collaboration and innovation can support sustainability in healthcare and each stakeholder’s role in making it happen.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting